NCT02022423

Brief Summary

Peripheral arterial disease (PAD) is a significant vascular condition affecting millions of adults. Exercise such as walking is highly effective for reducing PAD symptoms such as claudication (pain with walking) and improving physical function. The trial examines the efficacy of a internet-delivered walking program for patients with PAD. Comparator groups including telephone counselling, the combination of internet-delivered walking program + telephone counseling, or usual care. The primary outcome of interest is maximal walking distance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
172

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 5, 2013

Completed
22 days until next milestone

First Posted

Study publicly available on registry

December 27, 2013

Completed
8 months until next milestone

Study Start

First participant enrolled

September 1, 2014

Completed
7.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

December 21, 2021

Status Verified

December 1, 2021

Enrollment Period

7.3 years

First QC Date

December 5, 2013

Last Update Submit

December 20, 2021

Conditions

Keywords

peripheral arterial diseasewalkingeHealthtelehealth

Outcome Measures

Primary Outcomes (4)

  • Change in maximal walking distance

    measured using the Gardner-Skinner protocol treadmill test, noting time to moderate claudication

    Baseline to 4 months

  • Change in PAD-specific health-related quality of life

    measured using disease specific Peripheral Artery Questionnaire (PAQ) which uses scale scores of 0 to 100, with high numbers indicating better outcomes.

    Baseline to 4 months

  • Change in general health-related quality of life

    measured using the EuroQol 5 Dimension Scale (EQ-5D) which is comprised of a descriptive system questionnaire containing 5 questions and a visual analogue scale ranging from 0 to 100 with 0 being worse health state imaginable and 100 being best health state imaginable. The descriptive system questionnaire is scored by assigning a 1-digit number to the participant's answer choice for each of the 5 questions, then combining each into a 5-digit number indicating their health state.

    Baseline to 4 months

  • Change in global health-related quality of life

    measured using the Patient Reported Outcomes Measurement Information System (PROMIS) Questionnaire that includes questions from physical, mental, and social health domains and is scored using a T-score metric. A higher score equals more of a concept being measured which can indicate better or worse outcomes depending on the concept being measured.

    Baseline to 4 months

Secondary Outcomes (5)

  • Change in pain-free walking distance

    Baseline to 4 months

  • Change in maximal walking distance

    Baseline to 12 months

  • Change in PAD-specific health-related quality of life

    Baseline to 12 months

  • Change in general health-related quality of life

    Baseline to 12 months

  • Change in global health-related quality of life

    Baseline to 12 months

Study Arms (4)

Telephone Counseling

ACTIVE COMPARATOR

Weekly telephone calls to assess compliance to exercise prescription and discuss various topics related to adoption and adherence to walking programs

Behavioral: Telephone counseling

Internet-based walking program

EXPERIMENTAL

Weekly automated goals are delivered via email to subject; goals are based on previous week's step count accumulation.

Behavioral: Internet-based walking program

Telephone counseling and Internet-based walking program

EXPERIMENTAL

Weekly telephone calls to assess compliance to exercise prescription and discuss various topics related to adoption and adherence to walking programs plus weekly automated goals are delivered via email to subject; goals are based on previous week's step count accumulation.

Behavioral: Telephone counselingBehavioral: Internet-based walking program

Usual Care

NO INTERVENTION

Subjects will continue with their health care as usual

Interventions

4 months of weekly contact to update exercise prescription and discuss barriers and challenges to adherence

Telephone CounselingTelephone counseling and Internet-based walking program

Four-month Internet-based walking program consisting of weekly step count goals

Internet-based walking programTelephone counseling and Internet-based walking program

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 40
  • Diagnosis of PAD due to atherosclerosis, documented by 1 or more of the following:
  • documented ankle brachial index (ABI) ≤ 0.9 in at least one leg
  • toe brachial index ≤ .70 for participants with an ABI \> 1.3
  • documented arterial disease by MRI, CT or angiogram Ability to walk at least 150 feet without the assistance of a cane or walker. Are sedentary (defined as \< 150 minutes per week of physical activity). Able to obtain medical clearance from a primary care provider, cardiologist, vascular specialist, endocrinologist, nurse practitioner, or physician assistant.
  • Competent to give informed consent. Have regular access to a computer with an Internet connection that allows software downloading.
  • Be a regular email user (check email at least once a week).

You may not qualify if:

  • PAD due to non-atherosclerotic causes such as trauma, entrapment syndromes or congenital anomalies.
  • No primary provider, or cardiologist or vascular provider Life expectancy of under 1-year Co-morbidities which limit physical activity to a severe degree (defined as the inability to walk a grocery store aisle unassisted) Signs of critical limb ischemia and/or planned peripheral revascularization in the next 12-months
  • A diagnoses of any of the following cardiovascular events in the past 3 months:
  • stroke/transient ischemic attack
  • myocardial infarction
  • unstable angina
  • percutaneous coronary intervention
  • coronary bypass graft surgery A diagnoses of any of the following cardiovascular conditions
  • severe valve disease untreated
  • complex arrhythmia untreated
  • New York Heart Association class III-IV heart failure Current substance abuse, or significant psychiatric disorder, or dementia which limits the participant's ability to follow the study protocol Pregnancy Non-English speaking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Alabama Birmingham

Birmingham, Alabama, 35294, United States

Location

University of Michigan

Ann Arbor, Michigan, 48106, United States

Location

Related Publications (2)

  • Kumar AM, Lyden AK, Carlozzi NE, Sen A, Richardson CR, Jackson EA. The Physical Activity Daily (PAD) Trial: The rationale and design of a randomized controlled trial evaluating an internet walking program to improve maximal walking distance among patients with peripheral arterial disease. Contemp Clin Trials. 2018 Apr;67:23-30. doi: 10.1016/j.cct.2017.12.009. Epub 2017 Dec 21.

    PMID: 29274894BACKGROUND
  • Jones R, Enogela EM, Zumbro EL, Soukhamneut P, Richardson CR, Buford TW, Jackson EA. Assessment of Frailty Among Older Adults in the Physical Activity Daily Trial. J Appl Gerontol. 2024 Oct;43(10):1428-1437. doi: 10.1177/07334648241244690. Epub 2024 Apr 24.

MeSH Terms

Conditions

Peripheral Arterial Disease

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular Diseases

Study Officials

  • Elizabeth A. Jackson, MD MPH FACC

    University of Alabama at Birmingahm

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Four groups are included in this study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 5, 2013

First Posted

December 27, 2013

Study Start

September 1, 2014

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

December 21, 2021

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations